Genes involved in hemorrhagic transformations that follow recombinant t-PA treatment in stroke patients

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke

(2012) Alberto del Río-Espínola et al.   ANNALS OF NEUROLOGY

Role of the MMP9 Gene in Hemorrhagic Transformations After Tissue-Type Plasminogen Activator Treatment in Stroke Patients

(2012) Israel Fernández-Cadenas et al.   STROKE

VAP-1/SSAO Plasma Activity and Brain Expression in Human Hemorrhagic Stroke

(2011) Mar Hernandez-Guillamon et al.   CEREBROVASCULAR DISEASES

Brain Perihematoma Genomic Profile Following Spontaneous Human Intracerebral Hemorrhage

(2011) Anna Rosell et al.   PLoS One

Signatures of cardioembolic and large-vessel ischemic stroke

(2010) Glen C. Jickling et al.   ANNALS OF NEUROLOGY

Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling

(2010) T. L. Barr et al.   NEUROLOGY

Plasma VAP-1/SSAO Activity Predicts Intracranial Hemorrhages and Adverse Neurological Outcome After Tissue Plasminogen Activator Treatment in Stroke

(2010) Mar Hernandez-Guillamon et al.   STROKE

Hospital Arrival Time and Intravenous t-PA Use in US Academic Medical Centers, 2001–2004

(2009) Judith H. Lichtman et al.   STROKE

Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release

(2008) Eloy Cuadrado et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke

(2008) Anna Rosell et al.   STROKE